Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121711) titled 'A Deep Learning-Radiomics Fusion Model Based on Super-Resolution Reconstruction Multimodal Ultrasound for Breast Cancer Neoadjuvant Chemotherapy Response Prediction' on April 1.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University

Condition: Locally Advanced Breast Cancer

Intervention: Gold Standard:Postoperative pathology: pathological complete response (pCR) defined as no residual invasive carcinoma in breast and axillary lymph nodes (ypT0/is ypN0), per Chinese Expert Consensus on Neoadjuvant Therapy for Breast Cancer (...